Immutep Ltd News

Immutep Ltd Advances Cancer Immunotherapy Trials

TipRanksJul 30 23:07 ET

Clinical Trials in Cancer and Autoimmune Diseases: Immutep's CEO Marc Voigt Provides an Update

sharecafeJul 30 03:30 ET

ImpediMed Target Price Cut 12% to A$0.18/Share by Wilsons>IMM.AU

Dow JonesJul 29 18:59 ET

Immutep Ltd Ownership Shifts With Regal Funds Increase

TipRanksJul 26 03:11 ET

Immutep Target Price Cut 7.1% to A$1.05/Share by Wilsons>IMM.AU

Dow JonesJul 24 18:18 ET

Immutep Secures US FDA Guidance for Phase Three Lung Cancer Trial

MT NewswiresJul 22 01:03 ET

Guess Which ASX Healthcare Stock Is Surging on Big FDA News

The Motley FoolJul 21 22:47 ET

Immutep Receives Positive FDA Feedback

sharecafeJul 21 22:23 ET

Why 29Metals, Immutep, Insignia, and Perenti Shares Are Pushing Higher Today

The Motley FoolJul 21 22:16 ET

Jefferies Remains a Buy on Immutep Ltd (PRRUF)

TipRanksJul 18 08:17 ET

Immutep Secures Regulatory Clearance for Phase 1 Antibody Study in Autoimmune Diseases; Shares Up 3%

MT NewswiresJul 16 20:41 ET

Rising US Rate Cut Bets Lift Australian Shares to Record High

MT NewswiresJul 12 02:46 ET

Immutep Surges 19% Following Positive Results in Head, Neck Cancer Trial

MT NewswiresJul 12 00:52 ET

Stocks of the Hour: Immutep, Middle Island Resources, Inca Minerals

sharecafeJul 11 22:03 ET

Why Is This ASX Healthcare Stock Rocketing 25% on Friday?

The Motley FoolJul 11 20:32 ET

Why Coronado Global, EML, Immutep, and Lendlease Shares Are Storming Higher

The Motley FoolJul 1 00:26 ET

Immutep Target Price Cut 6% to A$0.75/Share by Bell Potter

Dow JonesJun 30 19:45 ET

Immutep Price Target Cut to $6.00/Share From $7.00 by Baird

Dow JonesJun 27 07:19 ET

Immutep Is Maintained at Outperform by Baird

Dow JonesJun 27 07:19 ET

Immutep Reports Positive Results in Drug Combination Trial for Head, Neck Cancer

MT NewswiresJun 27 03:54 ET